Alternatives · ranked for speed
Henry Meds lands at #6 on our ranking with a Rx-Readiness Score of 85/100. If it isn't the right fit, here are the strongest alternatives on our shortlist — scored on the same readiness rubric of speed to first dose, flat pricing, no-video signup, access, molecule choice and a clean off-ramp.
Our #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
Ranked #2 · Grade B+
A high-disclosure program with clean async onboarding and both molecules nationwide — you pay more, but the price and the process are legible.
Ranked #3 · Grade B+
Identical low pricing on both molecules plus built-in coaching — the flat-fee simplicity is a real time-saver if you also want a little accountability.
Ranked #4 · Grade B+
A polished, app-first mass-market brand with a fast async funnel — dependable and familiar, though tirzepatide pricing isn't consistently posted.
Ranked #5 · Grade B
A heavyweight platform with brand-name access and insurance navigation — powerful if you want FDA-approved product, but the compounded pricing is opaque and can slow a quick decision.
Ranked #7 · Grade B−
A genuinely support-forward program with a strong care team and fair pricing — but limited state coverage and tiered pricing make it a slower, narrower fit for a quick nationwide decision.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.